Tiziana Life Sciences Ltd

TLSA chart

Tiziana Life Sciences Ltd news

• Tiziana Life Sciences Ltd Estimates – NASDAQ:TLSA

  TradingView · Oct 23, 7:49 PM EDT

• Cyclin-Dependent Kinase Inhibitor Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 50+ Leading Players Wheeling the Therapeutics Landscape

  StreetInsider · Oct 23, 10:58 AM EDT

• Management and deal teams from Tiziana (TLSA) will attend a Toronto MS meeting October 21–23.

  Stock Titan · Oct 21, 7:00 AM EDT

• Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto

  Yahoo Finance · Oct 21, 7:00 AM EDT

• All 14 patients in Tiziana’s multiple sclerosis access program had stable or improved disease within six months.

  Stock Titan · Oct 21, 7:00 AM EDT

• Tiziana completes dosing in Phase 2 Alzheimer’s trial of intranasal foralumab

  proactiveinvestors.com · Oct 16, 8:38 AM EDT

• Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease

  Yahoo Finance · Oct 16, 7:00 AM EDT

• Tiziana Life Sciences seeks FDA orphan drug status for nasal MSA therapy

  proactiveinvestors.com · Sep 30, 8:54 AM EDT

• MARKETS LIVE: Wall Street closes mixed as cooling inflation lifts Nasdaq

  proactiveinvestors.com · Sep 30, 7:14 AM EDT

• Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

  Yahoo Finance · Sep 30, 7:00 AM EDT

• Tiziana Life Sciences doses first ALS patients in Phase 2a Foralumab trial

  Yahoo Finance · Sep 29, 9:53 AM EDT

• Tiziana doses first three patients in ALS trial of nasal antibody foralumab

  proactiveinvestors.com · Sep 28, 9:14 AM EDT

Tiziana Life Sciences Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-21
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-16
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-16
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-21
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-17
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-24
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-06
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-04
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-31
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-22

About Tiziana Life Sciences Ltd

Ticker

TLSA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

London, England, United Kingdom

Incorporated in

Bermuda

Fiscal year end

December 31

SEC CIK

1723069

Former names

Tiziana Life Sciences plc

Frequently asked questions